3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
68
Lymphoma, Non-Hodgkin
53
Lymphoma, Large B-Cell, Diffuse
47
Hodgkin Disease
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Leukemia, Myeloid, Acute
41
Small Cell Lung Carcinoma
37
Leukemia
37
Burkitt Lymphoma
32
Lymphoma, Mantle-Cell
29
Lymphoma, Follicular
28
Lung Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Multiple Myeloma
19
Congenital Abnormalities
18
Lymphoma, Large-Cell, Immunoblastic
17
Lymphoma, Large-Cell, Anaplastic
17
Recurrence
15
Lymphoma, B-Cell, Marginal Zone
15
Lymphoma, B-Cell
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Neuroblastoma
13
Neoplasms
13
Myelodysplastic Syndromes
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell
10
Immunoblastic Lymphadenopathy
10
Sarcoma
9
Myeloproliferative Disorders
9
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Etoposide
×
Clear all
No trials found.